Novartis bolsters radioligand portfolio with $1bn Mariana buy
May 7, 2024SCG and A*STAR to develop better stem cell manufacturing
May 6, 2024New modalities drive revenue for Repligen despite 'lumpy’ CDMO demand
May 6, 2024Organizational flips help B-I deal with complexity challenges, says expert
May 6, 2024